Enforcement and Compliance with Price Ceilings on Essential Medicines

Ajay Bhaskarabhatla
Additional contact information
Ajay Bhaskarabhatla: Erasmus University Rotterdam

Chapter Chapter 8 in Regulating Pharmaceutical Prices in India, 2018, pp 197-227 from Springer

Abstract: Abstract The effectiveness of price control regulations depends as much on the design of the policy as on implementation. Yet rarely if ever studies examine the enforcement and compliance aspects of such price control regulations. In this chapter, we address this gap in the literature by examining the extent of compliance with price ceilings imposed on essential medicines in India in 2013 and how it has changed in response to enforcement efforts. We estimate the extent of noncompliance with the 2013 DPCO and the total overcharged amount. We identify firms and markets with significant levels of noncompliance. We also reflect on whether the regulator has followed a targeted approach to enforcement to induce compliance and whether such targeting has had any impact on overall compliance. We examine efforts by the regulator to ask firms to self-report their prices and whether that has had any impact on inducing compliance.

Date: 2018
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:isbchp:978-3-319-93393-1_8

Ordering information: This item can be ordered from
http://www.springer.com/9783319933931

DOI: 10.1007/978-3-319-93393-1_8

Access Statistics for this chapter

More chapters in India Studies in Business and Economics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().